Tulstrup, M, Grosjean, M, Nielsen, S N, Grell, K, Wolthers, B O, Wegener, P S, Jonsson, O G, Lund, B, Harila-Saari, A, Abrahamsson, J, Vaitkeviciene, G, Pruunsild, K, Toft, N, Holm, M, Hulegårdh, E, Liestøl, S, Griskevicius, L, Punab, M, Wang, J, Carroll, W L, Zhang, Z, Dalgaard, M D, Gupta, R, Nersting, J & Schmiegelow, K 2018, ' NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia ', Leukemia, vol. 32, no. 12, pp. 2527–2535 . https://doi.org/10.1038/s41375-018-0245-3 Tulstrup, M, Grosjean, M, Nielsen, S N, Grell, K, Wolthers, B O, Wegener, P S, Jonsson, O G, Lund, B, Harila-Saari, A, Abrahamsson, J, Vaitkeviciene, G, Pruunsild, K, Toft, N, Holm, M, Hulegårdh, E, Liestøl, S, Griskevicius, L, Punab, M, Wang, J, Carroll, W L, Zhang, Z, Dalgaard, M D, Gupta, R, Nersting, J & Schmiegelow, K 2018, ' NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia ', Leukemia, vol. 32, no. 12, pp. 2527-2535 . https://doi.org/10.1038/s41375-018-0245-3